Cargando…
A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway
Hyperphosphatemia is commonly present in end-stage renal disease. Klotho (KL) is implicated in phosphate homeostasis since it acts as obligate co-receptor for the fibroblast growth factor 23 (FGF23), a major phosphaturic hormone. We hypothesized that genetic variation in the KL gene might be associa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517886/ https://www.ncbi.nlm.nih.gov/pubmed/31013726 http://dx.doi.org/10.3390/jcm8040500 |
_version_ | 1783418344588705792 |
---|---|
author | Martín-Núñez, Ernesto Donate-Correa, Javier Kannengiesser, Caroline De Brauwere, David-Paul Leroy, Christine Oudin, Claire Friedlander, Gérard Prieto-Morín, Carol Tagua, Víctor G. Ureña-Torres, Pablo A. Navarro-González, Juan F. |
author_facet | Martín-Núñez, Ernesto Donate-Correa, Javier Kannengiesser, Caroline De Brauwere, David-Paul Leroy, Christine Oudin, Claire Friedlander, Gérard Prieto-Morín, Carol Tagua, Víctor G. Ureña-Torres, Pablo A. Navarro-González, Juan F. |
author_sort | Martín-Núñez, Ernesto |
collection | PubMed |
description | Hyperphosphatemia is commonly present in end-stage renal disease. Klotho (KL) is implicated in phosphate homeostasis since it acts as obligate co-receptor for the fibroblast growth factor 23 (FGF23), a major phosphaturic hormone. We hypothesized that genetic variation in the KL gene might be associated with alterations in phosphate homeostasis resulting in hyperphosphatemia. We performed sequencing for determining KL gene variants in a group of resistant hyperphosphatemic dialysis patients. In a 67-year-old female, blood DNA sequencing revealed a heterozygous deletion of a T at position 1041 (c.1041delT) in exon 2. This variation caused a frameshift with substitution of isoleucine for phenylalanine and introduction of a premature termination codon (p.Ile348Phefs*28). cDNA sequencing showed absence of deletion-carrier transcripts in peripheral blood mononuclear cells suggesting degradation of these through a nonsense-mediated RNA decay pathway. Experiments in vitro showed that p.Ile348Phefs*28 variant impaired FGF23 signaling pathway, indicating a functional inactivation of the gene. In the patient, serum levels of KL were 2.9-fold lower than the mean level of a group of matched dialysis subjects, suggesting a compromise in the circulating protein concentration due to haploinsufficiency. These findings provide a new loss-of-function variant in the human KL gene, suggesting that genetic determinants might be associated to clinical resistant hyperphosphatemia. |
format | Online Article Text |
id | pubmed-6517886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65178862019-05-31 A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway Martín-Núñez, Ernesto Donate-Correa, Javier Kannengiesser, Caroline De Brauwere, David-Paul Leroy, Christine Oudin, Claire Friedlander, Gérard Prieto-Morín, Carol Tagua, Víctor G. Ureña-Torres, Pablo A. Navarro-González, Juan F. J Clin Med Article Hyperphosphatemia is commonly present in end-stage renal disease. Klotho (KL) is implicated in phosphate homeostasis since it acts as obligate co-receptor for the fibroblast growth factor 23 (FGF23), a major phosphaturic hormone. We hypothesized that genetic variation in the KL gene might be associated with alterations in phosphate homeostasis resulting in hyperphosphatemia. We performed sequencing for determining KL gene variants in a group of resistant hyperphosphatemic dialysis patients. In a 67-year-old female, blood DNA sequencing revealed a heterozygous deletion of a T at position 1041 (c.1041delT) in exon 2. This variation caused a frameshift with substitution of isoleucine for phenylalanine and introduction of a premature termination codon (p.Ile348Phefs*28). cDNA sequencing showed absence of deletion-carrier transcripts in peripheral blood mononuclear cells suggesting degradation of these through a nonsense-mediated RNA decay pathway. Experiments in vitro showed that p.Ile348Phefs*28 variant impaired FGF23 signaling pathway, indicating a functional inactivation of the gene. In the patient, serum levels of KL were 2.9-fold lower than the mean level of a group of matched dialysis subjects, suggesting a compromise in the circulating protein concentration due to haploinsufficiency. These findings provide a new loss-of-function variant in the human KL gene, suggesting that genetic determinants might be associated to clinical resistant hyperphosphatemia. MDPI 2019-04-12 /pmc/articles/PMC6517886/ /pubmed/31013726 http://dx.doi.org/10.3390/jcm8040500 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martín-Núñez, Ernesto Donate-Correa, Javier Kannengiesser, Caroline De Brauwere, David-Paul Leroy, Christine Oudin, Claire Friedlander, Gérard Prieto-Morín, Carol Tagua, Víctor G. Ureña-Torres, Pablo A. Navarro-González, Juan F. A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway |
title | A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway |
title_full | A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway |
title_fullStr | A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway |
title_full_unstemmed | A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway |
title_short | A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway |
title_sort | novel heterozygous deletion variant in klotho gene leading to haploinsufficiency and impairment of fibroblast growth factor 23 signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517886/ https://www.ncbi.nlm.nih.gov/pubmed/31013726 http://dx.doi.org/10.3390/jcm8040500 |
work_keys_str_mv | AT martinnunezernesto anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT donatecorreajavier anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT kannengiessercaroline anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT debrauweredavidpaul anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT leroychristine anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT oudinclaire anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT friedlandergerard anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT prietomorincarol anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT taguavictorg anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT urenatorrespabloa anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT navarrogonzalezjuanf anovelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT martinnunezernesto novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT donatecorreajavier novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT kannengiessercaroline novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT debrauweredavidpaul novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT leroychristine novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT oudinclaire novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT friedlandergerard novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT prietomorincarol novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT taguavictorg novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT urenatorrespabloa novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway AT navarrogonzalezjuanf novelheterozygousdeletionvariantinklothogeneleadingtohaploinsufficiencyandimpairmentoffibroblastgrowthfactor23signalingpathway |